 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trevena (NASDAQ:TRVN  Get Free Report) and AC Immune (NASDAQ:ACIU  Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two...

AC Immune (NASDAQ:ACIU) and Trevena (NASDAQ:TRVN) Critical Analysis

This price move could indicate a change in the trend, and may be a sell signal for investors...

AC Immune SA (ACIU, $3.02) price exceeded its 50-day Moving Average on September 15, 2023

This price move could be a signal that ACIU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

AC Immune SA (ACIU, $3.02) price may climb as it broke lower Bollinger Band on Sep 15, 2023

This is a signal that ACIU's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

AC Immune SA (ACIU, $3.02) Stochastic Oscillator left the oversold zone on September 15, 2023

Over the last three days, A.I.dvisor has detected that ACIU's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

AC Immune SA (ACIU, $3.24) Aroon Indicator entered an Uptrend on September 13, 2023.

AC Immune SA (ACIU, $3.36) Aroon Indicator entered an Uptrend on September 12, 2023.

AC Immune SA (ACIU, $3.33) Aroon Indicator entered an Uptrend on September 11, 2023.

AC Immune SA (ACIU, $3.29) Aroon Indicator entered an Uptrend on September 08, 2023.

AC Immune SA (ACIU, $3.19) Aroon Indicator entered an Uptrend on September 06, 2023.

This is a signal that ACIU's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

AC Immune SA (ACIU, $3.19) Stochastic Oscillator left the overbought zone on September 06, 2023

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Watchers	3,714
52-Wk Low	$1.68
52-Wk High	$3.83

Market Cap	$250.03M
Volume (M)	34.00
52-Wk High	$3.83
52-Wk Low	$1.68

ACIU AC Immune SA

About

Feed

News

Sentiment

Earnings

Fundamentals